Q3 2010

Filed Nov 12, 2010 · 10-Q · 43 days after period end · 0001193125-10-258809

Q3 2010 · 10-Q

Revenue

$1.28M

no prior Q3 2009 on file

Net Income

-$1.41M

no prior Q3 2009 on file

EPS Diluted

-$0.01

no prior Q3 2009 on file

Operating Income-$4,556,518—

Operating Cash Flow

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 12, 2010 · 43 d after period end

Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR